Back

RxCe.com LLC

  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor Agonists

Pharmacologic Approaches to Diabetes Management: Glucagon-Like Peptide-1 Based Therapies

Diabetes mellitus remains a significant public health problem as a leading cause of death and micro- and macrovascular morbidity. The management of diabetes continues to evolve as new research, technology, and treatments allow for enhanced patient care. It is vital for health care providers, including physicians, nurses, and pharmacists, to be current with diabetes care guidelines, including the pharmacologic management of diabetes mellitus. This course will review glucagon-like peptide-1-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs. Dosing regimens, side effects, and monitoring parameters will be discussed. The role of GLP-1-based therapies within therapeutic regimens for patients with Type 2 diabetes mellitus will be discussed in the context of the updated American Diabetes Association Standards of Care in Diabetes 2023 guidelines.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 2 creditsAAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsPharmacyUp to 2 credits

MOC types

ABIM — Medical KnowledgeUp to 2 pointsABIM — Practice AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Paid

This provider typically $6.99

See fees on rxce.com

Listed by the provider · rxce.com

  • Enduring / On-demand
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Paid · this provider typically $6.99
  • Released
    Apr 3, 2026
  • Last day to claim credit
    Apr 4, 2029 2 years left